Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinobright Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the manufacture, distribution, and international export of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. Established in 1996 and headquartered in Shenzhen, the company has developed a robust global supply chain, serving markets across Africa, Southeast Asia, the Middle East, and Latin America. Their extensive product portfolio covers diverse therapeutic areas including antibiotics, analgesics, vitamins, and cardiovascular treatments. Sinobright is recognized for its expertise in navigating international regulatory requirements and providing comprehensive pharmaceutical sourcing solutions. The company operates several manufacturing bases and maintains a strong focus on quality assurance and GMP compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinobright Pharmaceutical Company.